comparemela.com

Latest Breaking News On - Thibaut roulon - Page 1 : comparemela.com

Nouscom Raises €67 5 million ($72 million) in

New specialist European and US life sciences investors join existing investors to enable Nouscom to continue advancing the clinical development of its.

United statesFrance generalGoran andoPasteur mutualitHakan gokerMarina udierRick davisThibaut roulonSylvie berrebiBristol myers squibbSociety for immunotherapy of cancerBandera coMerck co incBoehringer ingelheimFrontier technology sustainabilityEuropean fund of investment

Nouscom Raises €67 5 million ($72 million) in Oversubscribed Series C Financing Round

New specialist European and US life sciences investors join existing investors to enable Nouscom to continue advancing the clinical development of.

United statesFrance generalSylvie berrebiMarina udierPasteur mutualitRick davisGoran andoHakan gokerThibaut roulonSociety for immunotherapy of cancerNational cancer instituteJanssen research developmentAndera life sciencesBandera coBoehringer ingelheimEuropean fund of investment

Advicenne Provides an Update on Its Activities Following Its Annual General Meeting and Board of Directors Meeting on June 9, 2022

Changes in governance with the appointment of a new Chairman of the Board of Directors and a new Director Regrouping of all French Advicenne's teams in the new Paris headquarters to optimize

United statesFrance generalUnited kingdomHege hellstromThibaut roulonCatherine dunandCharlotte sibleyBpifrance investissementJean michel petitAshley tappPhilippe boucheronMary jane elliottDavide salviDidier laurensPrimex pharmaceuticalsFinalization of the company

Depixus Raises EUR 30 6M (USD 35 4M) in Series A Financing

/PRNewswire/ Depixus®, a biotechnology company developing a unique technology for the fast, accurate, and straightforward extraction of multiomic.

United kingdomFrance generalPrnewswire depixusThibaut roulonRonald lindsayGordon hamiltonArix bioscienceMark chinJohn berrimanLachlan mackinnonSteve allenInvestment programMajor innovation support programNature researchCommunications biologyLansdowne partners

Depixus Raises EUR 30 6M (USD 35 4M) in Series A Financing

- The financing will support development of a commercial instrument system based on the company's proprietary and disruptive MAGNA technology. - MAGNA is set to unlock the field of dynamic

United kingdomFrance generalPrnewswire depixusThibaut roulonRonald lindsayGordon hamiltonArix bioscienceMark chinJohn berrimanKostenloser wertpapierhandelLachlan mackinnonSteve allenInvestment programMajor innovation support programNature researchCommunications biology

vimarsana © 2020. All Rights Reserved.